Evidence map›Paper›PMID 31037646›Full record

ArticleMolecular neurobiology2019

S-Ketamine Reverses Hippocampal Dendritic Spine Deficits in Flinders Sensitive Line Rats Within 1 h of Administration.

Giulia Treccani, Maryam Ardalan, Fenghua Chen, Laura Musazzi, Maurizio Popoli, Gregers Wegener, Jens Randel Nyengaard, Heidi Kaastrup Müller

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. GluN2A: A Promising Target for Developing Novel Antidepressants.The international journal of neuropsychopharmacology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Effects of esketamine on depression-like behavior and dendritic spine plasticity in the prefrontal cortex neurons of spared nerve injury-induced depressed mice.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  19. Review
  20. Neural plasticity and depression treatment.IBRO neuroscience reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Giulia TreccaniTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Skovagervej 72, 8240, Risskov, Denmark.
Maryam ArdalanTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Skovagervej 72, 8240, Risskov, Denmark.
Fenghua ChenTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Skovagervej 72, 8240, Risskov, Denmark.
Laura MusazziLaboratory of Neuropsychopharmacology and Functional Neurogenomics - Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milan, Italy.
Maurizio PopoliLaboratory of Neuropsychopharmacology and Functional Neurogenomics - Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases, University of Milano, Milan, Italy.
Gregers WegenerTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Skovagervej 72, 8240, Risskov, Denmark.
Jens Randel NyengaardCore Center for Molecular Morphology, Section for Stereology and Microscopy, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Heidi Kaastrup MüllerTranslational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Skovagervej 72, 8240, Risskov, Denmark. heidi.muller@clin.au.dk.ORCID http://orcid.org/0000-0002-9842-8114
Aarhus University · DKUniversity of Milan · ITJohannes Gutenberg University Mainz · DE

Funding

Fondazione Cariplo 2014-1133Strategiske Forskningsråd DFF-5053-00103
6 · The paper itself

Abstract

When administered as a single subanesthetic dose, the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, produces rapid (within hours) and relatively sustained antidepressant actions even in treatment-resistant patients. Preclinical studies have shown that ketamine increases dendritic spine density and synaptic proteins in brain areas critical for the actions of antidepressants, yet the temporal relationship between structural changes and the onset of antidepressant action remains poorly understood. In this study, we examined the effects of a single dose of S-ketamine (15 mg/kg) on dendritic length, dendritic arborization, spine density, and spine morphology in the Flinders Sensitive and Flinders Resistant Line (FSL/FRL) rat model of depression. We found that already 1 h after injection with ketamine, apical dendritic spine deficits in CA1 pyramidal neurons of FSL rats were completely restored. Notably, the observed increase in spine density was attributable to regulation of both mushroom and long-thin spines. In contrast, ketamine had no effect on dendritic spine density in FRL rats. On the molecular level, ketamine normalized elevated levels of phospho-cofilin and the NMDA receptor subunits GluN2A and GluN2B and reversed homer3 deficiency in hippocampal synaptosomes of FSL rats. Taken together, our data suggest that rapid formation of new spines may provide an important structural substrate during the initial phase of ketamine's antidepressant action.

Indexed as

Actin Depolymerizing FactorsAnimalsDendritic SpinesHippocampusHomer Scaffolding ProteinsKetamineMalePhosphorylationRatsReceptors, N-Methyl-D-AspartateSynapsesSynaptosomesActin Depolymerizing FactorsEsketamineHomer3 protein, ratHomer Scaffolding ProteinsKetamineNR2B NMDA receptorReceptors, N-Methyl-D-AspartateAntidepressantsCofilinDendritic SpinesHomer3KetamineSynaptosomes

Identifiers

PMID31037646
OpenAlexW2942631248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.